MedTrace Logo

n-3 and n-6 Fatty Acids in Rheumatoid Arthritis

NCT01179971 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-08-26

No results posted yet for this study

Summary

Purpose: To investigate into the differential effects of polyunsaturated fatty acids as compared to standard control therapy (olive oil) on disease activity and biochemical parameters in patients with rheumatoid arthritis (RA), resp. psoriasis arthritis (PA).

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish oil, gamma-linolenic acid

3 g/d DHA + EPA

Sponsors & Collaborators

  • University of Jena

    collaborator OTHER

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Rainer Stange, MD, PhD · Immanuel Krankenhaus and Charite Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-01-31
Completion
2010-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179971 on ClinicalTrials.gov